GABARAPL1 and hepatocellular carcinoma: It had been reported that lower GABARAPL1 expression is correlated with poor prognosis of hepatocellular carcinoma and lymph node-positive breast cancer patients [32,33], which might indicate that GABARAPL1 is a negative regulator of cancer progression.